337 related articles for article (PubMed ID: 17124010)
1. The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma.
Schopperle WM; DeWolf WC
Stem Cells; 2007 Mar; 25(3):723-30. PubMed ID: 17124010
[TBL] [Abstract][Full Text] [Related]
2. The human cancer and stem cell marker podocalyxin interacts with the glucose-3-transporter in malignant pluripotent stem cells.
Schopperle WM; Lee JM; Dewolf WC
Biochem Biophys Res Commun; 2010 Jul; 398(3):372-6. PubMed ID: 20599725
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT.
Damjanov I; Horvat B; Gibas Z
Lab Invest; 1993 Feb; 68(2):220-32. PubMed ID: 7680083
[TBL] [Abstract][Full Text] [Related]
4. Isolation of human embryonal carcinoma stem cells by immunomagnetic sorting.
Przyborski SA
Stem Cells; 2001; 19(6):500-4. PubMed ID: 11713341
[TBL] [Abstract][Full Text] [Related]
5. Human Wnt-13 is developmentally regulated during the differentiation of NTERA-2 pluripotent human embryonal carcinoma cells.
Wakeman JA; Walsh J; Andrews PW
Oncogene; 1998 Jul; 17(2):179-86. PubMed ID: 9674702
[TBL] [Abstract][Full Text] [Related]
6. The CDK inhibitor p27 enhances neural differentiation in pluripotent NTERA2 human EC cells, but does not permit differentiation of 2102Ep nullipotent human EC cells.
Bahrami AR; Matin MM; Andrews PW
Mech Dev; 2005 Sep; 122(9):1034-42. PubMed ID: 16023837
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD30 and CD30 ligand in cultured cell lines from human germ-cell tumors.
Pera MF; Bennett W; Cerretti DP
Lab Invest; 1997 Apr; 76(4):497-504. PubMed ID: 9111512
[TBL] [Abstract][Full Text] [Related]
8. Identification of stem cell marker-positive cells by immunofluorescence in term human amnion.
Miki T; Mitamura K; Ross MA; Stolz DB; Strom SC
J Reprod Immunol; 2007 Oct; 75(2):91-6. PubMed ID: 17493686
[TBL] [Abstract][Full Text] [Related]
9. Heat shock 70-kDa protein 8 isoform 1 is expressed on the surface of human embryonic stem cells and downregulated upon differentiation.
Son YS; Park JH; Kang YK; Park JS; Choi HS; Lim JY; Lee JE; Lee JB; Ko MS; Kim YS; Ko JH; Yoon HS; Lee KW; Seong RH; Moon SY; Ryu CJ; Hong HJ
Stem Cells; 2005; 23(10):1502-13. PubMed ID: 16100000
[TBL] [Abstract][Full Text] [Related]
10. Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells.
Chadalavada RS; Korkola JE; Houldsworth J; Olshen AB; Bosl GJ; Studer L; Chaganti RS
Stem Cells; 2007 Mar; 25(3):771-8. PubMed ID: 17138961
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the Pluripotent Stem Cell Marker Podocalyxin in Prostate Cancer.
Heath EI; Heilbrun LK; Smith D; Schopperle WM; Ju Y; Bolton S; Ahmed Q; Sakr WA
Anticancer Res; 2018 Nov; 38(11):6361-6366. PubMed ID: 30396958
[TBL] [Abstract][Full Text] [Related]
12. Derivation of embryonic stem cell line from frozen human embryos and neural differentiation.
Tan JC; Li Y; Qu WY; Liu LY; Jiang L; Sun KL
Neuroreport; 2008 Oct; 19(15):1451-5. PubMed ID: 18797296
[TBL] [Abstract][Full Text] [Related]
13. Expression of pluripotent stem cell markers in the human fetal ovary.
Kerr CL; Hill CM; Blumenthal PD; Gearhart JD
Hum Reprod; 2008 Mar; 23(3):589-99. PubMed ID: 18203707
[TBL] [Abstract][Full Text] [Related]
14. Extrinsic factors derived from mouse embryonal carcinoma cell lines maintain pluripotency of mouse embryonic stem cells through a novel signal pathway.
Kawazoe S; Ikeda N; Miki K; Shibuya M; Morikawa K; Nakano S; Oshimura M; Hisatome I; Shirayoshi Y
Dev Growth Differ; 2009 Feb; 51(2):81-93. PubMed ID: 19207180
[TBL] [Abstract][Full Text] [Related]
15. Role of retinoic acid in the differentiation of embryonal carcinoma and embryonic stem cells.
Soprano DR; Teets BW; Soprano KJ
Vitam Horm; 2007; 75():69-95. PubMed ID: 17368312
[TBL] [Abstract][Full Text] [Related]
16. The secreted glycoprotein CREG enhances differentiation of NTERA-2 human embryonal carcinoma cells.
Veal E; Groisman R; Eisenstein M; Gill G
Oncogene; 2000 Apr; 19(17):2120-8. PubMed ID: 10815803
[TBL] [Abstract][Full Text] [Related]
17. Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1.
Choo AB; Tan HL; Ang SN; Fong WJ; Chin A; Lo J; Zheng L; Hentze H; Philp RJ; Oh SK; Yap M
Stem Cells; 2008 Jun; 26(6):1454-63. PubMed ID: 18356574
[TBL] [Abstract][Full Text] [Related]
18. The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan.
Badcock G; Pigott C; Goepel J; Andrews PW
Cancer Res; 1999 Sep; 59(18):4715-9. PubMed ID: 10493530
[TBL] [Abstract][Full Text] [Related]
19. Human embryonal carcinoma tumor antigen, Gp200/GCTM-2, is podocalyxin.
Schopperle WM; Kershaw DB; DeWolf WC
Biochem Biophys Res Commun; 2003 Jan; 300(2):285-90. PubMed ID: 12504081
[TBL] [Abstract][Full Text] [Related]
20. A novel cell-surface marker found on human embryonic hepatoblasts and a subpopulation of hepatic biliary epithelial cells.
Stamp L; Crosby HA; Hawes SM; Strain AJ; Pera MF
Stem Cells; 2005; 23(1):103-12. PubMed ID: 15625127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
